Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (100)

Latest Posts

About This Stock More About This Stock
Dogs Of The Dow Underperformance Gap Widening
Article By: David Templeton
Sunday, June 18, 2017 7:39 PM EDT
The first six months of the year are nearly behind us so I thought it appropriate to provide an update on the performance for the 2017 Dogs of the Dow.
In this article: BA, CAT, CVX, IBM, KO, MRK, PFE, VZ, XOM, CSCO
Read
Biotech Avoids Tech Wreck Of June 9
Article By: Rod Raynovich
Monday, June 12, 2017 1:48 AM EDT
A big part of 2017 investing strategy will be picking the right sector. Healthcare appears to offer modest returns with a dividend play.
In this article: BAC, BMY, JNJ, MRK, PFE, IBB, AAPL, AMZN, GILD, NFLX, NVDA, TSLA, SMH, XBI, XLE, XLF, XLV, FB, ABBV, GOOGL, BLUE
Read
Biotech Fades After ASCO Abstract Rally
Article By: Rod Raynovich
Friday, May 26, 2017 6:29 PM EDT
Biotechs faded today now that the rush of oncology drug news cooled down. Today was dominated by the “red screen” with profit taking mainly in smaller caps and momentum driven oncology stocks.
In this article: MRK, ALNY, ALXN, BMRN, INCY, CELG, CLVS, VRTX, ZIOP, JUNO, PBYI, EPZM, GLYC, KITE, TSRO
Read
Sensex Opens Higher; Lupin Plunges 5.5% On Weak Q4 Numbers
Article By: Equitymaster India
Thursday, May 25, 2017 1:21 AM EDT
Share markets in India have opened the day on a positive note. The BSE Sensex is trading higher by 106 points while the NSE Nifty is trading higher by 22 points.
In this article: MRK, WIT, SMPQY, INFY, KENSD
Read
ASCO Abstracts Week: Biotech Trends And Hot Stocks
Article By: Rod Raynovich
Monday, May 22, 2017 10:58 PM EDT
Today Amgen was down over 2 % on news that its osteoporosis treatment Evenity is unlikely to win FDA approval this year because of a safety risk. Radius Health was up over 6% to $37.30 as their rival drug Tymlos was approved in April.
In this article: MRK, ALNY, IBB, INCY, REGN, AMGN, CLVS, VRTX, FBT, XBI, PUMA, JUNO, EPZM, GLYC, KITE, BLUE, RDUS
Read

PARTNER HEADLINES

Latest Tweets for $MRK

No tweets yet!